M Pharmaceutical Inc (MPHMF) 0.1020 $MPHMF M Ph
Post# of 273254
Posted On: 09/20/2016 1:13:38 AM
M Pharmaceutical Inc (MPHMF) 0.1020 $MPHMF
M Pharmaceutical to Request DTC Eligibility to Improve Liquidity on the OTCQB
Marketwired - Thu Sep 17, 8:04AM CDT
M Pharmaceutical Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2) (the "Company"
, a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, today announced that it will engage a participant of the Depository Trust Company ("DTC" to request that the Company's securities become eligible for depository services. DTC Eligibility allows for a Company's securities to be traded electronically between brokerage accounts in the U.S.
M Pharmaceutical Inc. Names Highly-Regarded Electrical Engineer Dr. Michel Fattouche to Its Advisory Board
Marketwired - Fri Jun 19, 7:01AM CDT
M Pharmaceutical Inc., (CSE: MQ)(OTCQB: MPHMF), (the "Company" a Canadian company committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes, has named Dr. Michel Fattouche, a professor in the Department of Electrical and Computer Engineering at the University of Calgary, to the company's Advisory Board.
WILN: 1.55 (-0.06)
M Pharmaceutical to Request DTC Eligibility to Improve Liquidity on the OTCQB
Marketwired - Thu Sep 17, 8:04AM CDT
M Pharmaceutical Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2) (the "Company"
, a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, today announced that it will engage a participant of the Depository Trust Company ("DTC" to request that the Company's securities become eligible for depository services. DTC Eligibility allows for a Company's securities to be traded electronically between brokerage accounts in the U.S. M Pharmaceutical Inc. Names Highly-Regarded Electrical Engineer Dr. Michel Fattouche to Its Advisory Board
Marketwired - Fri Jun 19, 7:01AM CDT
M Pharmaceutical Inc., (CSE: MQ)(OTCQB: MPHMF), (the "Company"
a Canadian company committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes, has named Dr. Michel Fattouche, a professor in the Department of Electrical and Computer Engineering at the University of Calgary, to the company's Advisory Board. WILN: 1.55 (-0.06)
(0)
(0)Scroll down for more posts ▼